SICAV Funds performance table

help icon
fund namesort icon 1 mth 3 mth 12 mth ytd Inception Net assets Return Date
VF (Lux) - Valiant Aktien Nordamerika I 0% 3% 8% 8% 15% 74M 2014-12-31
VF (Lux) - Valiant Aktien Europa Z 0% -1% 4% 4% 11% 60M 2014-12-31
VF (Lux) - Valiant Aktien Europa S 0% -1% 4% 4% 12% 60M 2014-12-31
VF (Lux) - Valiant Aktien Europa I 0% -1% 3% 3% 12% 60M 2014-12-31
Vescore CYD Commodity L/S InstAL2 Dis -10% -17% -31% -33% 0% 0M 2011-09-30
Vescore CYD Commodity L/S InstAL Dis 0% 3% -1% -1% 0% - 2010-11-30
Vescore CYD Commodity L/S ANL Dis -11% -18% -32% -33% 0% 0M 2011-09-30
Vescore CYD Commodity L/S AL2 Dis -10% -17% -31% -32% 0% 0M 2011-09-30
Vescore CYD Commodity L/S AL Dis -11% -18% -32% -33% 0% 0M 2011-09-30
Vescore CYD Alpha Commodity InstAL2 2% 1% 1% 1% 0% 29M 2014-12-31
Vescore CYD Alpha Commodity InstAL 2% 1% 1% 1% 1% 29M 2014-12-31
Vescore CYD Alpha Commodity AL5 1% 2% 3% 2% 4% 267M 2012-03-31
Vescore CYD Alpha Commodity AL3 -1% 0% 0% 0% 2% 200M 2012-04-30
Vescore CYD Alpha Commodity AL2 1% 4% -1% 4% -1% 267M 2012-03-31
Vescore CYD Alpha Commodity AL -1% 0% 1% 0% 1% 200M 2012-04-30
Verrazzano European Long Short EI € 0% -1% 0% 0% 0% 80M 2014-12-31
Verrazzano Advantage European EI € -3% -2% 3% 3% 7% 141M 2014-12-31
Vaughan Nelson US SC Value Fd S/A USD 1% 6% 8% 8% 13% 233M 2014-12-31
Vaughan Nelson US SC Value Fd I/D USD 4% 3% 21% 5% 17% 233M 2014-08-31
Vaughan Nelson US SC Value Fd I/A USD 1% 6% 8% 8% 10% 233M 2014-12-31
Vaughan Nelson US SC Value Fd I/A EUR 4% 11% 23% 23% 22% 192M 2014-12-31
Vaughan Nelson US SC Value Fd H-I/A EUR 1% 6% 8% 8% 19% 192M 2014-12-31
Variopartner MIV Global Medtech I1 CHF 5% 1% 23% 25% 7% 397M 2013-10-31
Variopartner Helvetia Intl Euro Bond C1 0% 1% 10% 10% 4% 153M 2014-12-31
Variopartner Helvetia Intl Eq ex Eurp C1 2% 7% 27% 27% 5% 69M 2014-12-31
VAM World Growth Fund B $ -1% 3% -2% -2% 0% - 2014-12-31
VAM US Small Cap B 1% 9% 1% 1% 7% 16M 2014-12-31
VAM US Micro Cap B 6% 16% 5% 5% 10% 22M 2014-12-31
VAM US Large Cap B -1% 4% 3% 3% 6% 13M 2014-12-31
VAM Mid Cap Growth D 0% 1% 28% 0% 4% 40M 2014-01-31

All our data is licensed from Morningstar UK Ltd. Important legal information